IT1226727B - Farmaci precursori della dopamina. - Google Patents

Farmaci precursori della dopamina.

Info

Publication number
IT1226727B
IT1226727B IT8821543A IT2154388A IT1226727B IT 1226727 B IT1226727 B IT 1226727B IT 8821543 A IT8821543 A IT 8821543A IT 2154388 A IT2154388 A IT 2154388A IT 1226727 B IT1226727 B IT 1226727B
Authority
IT
Italy
Prior art keywords
dopamin
precursor drugs
compounds
formula
precursor
Prior art date
Application number
IT8821543A
Other languages
English (en)
Other versions
IT8821543A0 (it
Inventor
Cesare Casagrande
Francesco Santangelo
Original Assignee
Simes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simes filed Critical Simes
Priority to IT8821543A priority Critical patent/IT1226727B/it
Publication of IT8821543A0 publication Critical patent/IT8821543A0/it
Priority to JP1197894A priority patent/JPH0296556A/ja
Priority to DE8989114012T priority patent/DE68906609T2/de
Priority to EP89114012A priority patent/EP0352815B1/en
Priority to ES89114012T priority patent/ES2054949T3/es
Priority to US07/386,106 priority patent/US5013753A/en
Priority to AT89114012T priority patent/ATE89547T1/de
Application granted granted Critical
Publication of IT1226727B publication Critical patent/IT1226727B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT8821543A 1988-07-29 1988-07-29 Farmaci precursori della dopamina. IT1226727B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT8821543A IT1226727B (it) 1988-07-29 1988-07-29 Farmaci precursori della dopamina.
JP1197894A JPH0296556A (ja) 1988-07-29 1989-07-28 γ―グルタミル―Ｌ―ドパ誘導体、その製法ならびに該化合物を主成分として含むドパミン代用薬
DE8989114012T DE68906609T2 (de) 1988-07-29 1989-07-28 Dopamin-vorlaeufer.
EP89114012A EP0352815B1 (en) 1988-07-29 1989-07-28 Prodrugs of dopamine
ES89114012T ES2054949T3 (es) 1988-07-29 1989-07-28 Precursores de dopamina.
US07/386,106 US5013753A (en) 1988-07-29 1989-07-28 Prodrugs of dopamine
AT89114012T ATE89547T1 (de) 1988-07-29 1989-07-28 Dopamin-vorlaeufer.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8821543A IT1226727B (it) 1988-07-29 1988-07-29 Farmaci precursori della dopamina.

Publications (2)

Publication Number Publication Date
IT8821543A0 IT8821543A0 (it) 1988-07-29
IT1226727B true IT1226727B (it) 1991-02-05

Family

ID=11183351

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8821543A IT1226727B (it) 1988-07-29 1988-07-29 Farmaci precursori della dopamina.

Country Status (7)

Country Link
US (1) US5013753A (it)
EP (1) EP0352815B1 (it)
JP (1) JPH0296556A (it)
AT (1) ATE89547T1 (it)
DE (1) DE68906609T2 (it)
ES (1) ES2054949T3 (it)
IT (1) IT1226727B (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001724A1 (en) * 1989-07-27 1991-02-21 G.D. Searle & Co. Renal-selective prodrugs for the treatment of hypertension
DK1196414T3 (da) * 1999-06-25 2003-11-24 Vertex Pharma Prolægemiddel af carbamathæmmer for IMPDH
UA88792C2 (ru) * 2004-11-10 2009-11-25 Таргасепт, Інк. Гидроксибензоатные соли метаникотиновых соединений
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
DE102005022276A1 (de) * 2005-05-13 2006-11-16 Ellneuroxx Ltd. Derivate von Dihydroxyphenylalanin
TWI389889B (zh) * 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
EP2133337A1 (en) * 2006-05-09 2009-12-16 AstraZeneca AB Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine
EP2112923A1 (en) * 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
GB0713189D0 (en) * 2007-07-06 2007-08-15 Proximagen Ltd Amino acid derivatives
ES2322121B1 (es) * 2007-12-10 2010-04-19 Consejo Superior De Investigaciones Cientificas Nuevos derivados de aminoacidos dicarboxilicos y su aplicacion en el tratamiento de enfermedades neurodegenerativas.
AU2011256866B2 (en) 2010-05-20 2014-05-22 Astrazeneca Ab New process for the preparation of aryl substituted olefinic amines
CN105143174B (zh) 2013-03-15 2021-01-12 苏州泰飞尔医药有限公司 治疗帕金森疾病的新型高穿透力药物及其药物组合物
RU2021103000A (ru) 2014-10-21 2021-03-01 Эббви Инк. Пролекарства карбидопа и l-dopa и их применение для лечения болезни паркинсона
AR113908A1 (es) 2017-11-24 2020-06-24 H Lundbeck As Profármacos de catecolamina para uso en el tratamiento de la enfermedad de parkinson
JP6596483B2 (ja) * 2017-12-28 2019-10-23 テックフィールズ ファーマ カンパニー リミテッド パ−キンソン病治療用の新規高透過薬物及びその組成物
EP3880210A1 (en) 2018-11-15 2021-09-22 Abbvie Inc. Pharmaceutical formulations for subcutaneous administration
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
CN113677675B (zh) 2019-05-21 2024-07-26 H.隆德贝克有限公司 用于治疗帕金森病的新儿茶酚胺前药
CN113727979B (zh) 2019-05-21 2024-09-20 H.隆德贝克有限公司 用于治疗帕金森病的新儿茶酚胺前药
EP3972600B1 (en) 2019-05-21 2026-02-18 H. Lundbeck A/S Catecholamine carbamate prodrugs for use in the treatment of parkinson s disease
US12391650B2 (en) 2019-05-21 2025-08-19 H. Lundbeck A/S Catecholamine prodrugs for use in the treatment of Parkinson's disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947590A (en) * 1973-10-23 1976-03-30 Abbott Laboratories Compositions and methods of increasing renal blood flow with gamma-glutamyl amide of dopamine
US3891696A (en) * 1973-11-02 1975-06-24 Interx Research Corp Novel, transient pro-drug forms of l-dopa
US4035507A (en) * 1975-04-17 1977-07-12 Interx Research Corporation Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease
US4031242A (en) * 1975-09-11 1977-06-21 Abbott Laboratories Diacylated derivatives of γ-glutamyl dopamine
US4125626A (en) * 1977-01-17 1978-11-14 Mt. Sinai School Of Medicine Of The City University Of New York Synthesis and use of L-γ-glutamyl-DOPA

Also Published As

Publication number Publication date
DE68906609D1 (de) 1993-06-24
US5013753A (en) 1991-05-07
IT8821543A0 (it) 1988-07-29
ATE89547T1 (de) 1993-06-15
EP0352815B1 (en) 1993-05-19
JPH0296556A (ja) 1990-04-09
ES2054949T3 (es) 1994-08-16
EP0352815A1 (en) 1990-01-31
DE68906609T2 (de) 1993-08-26

Similar Documents

Publication Publication Date Title
IT1226727B (it) Farmaci precursori della dopamina.
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
SE8804629D0 (sv) New therapeutically active compounds
DK275488A (da) Indolonderivater
EP0303697A4 (en) Derivatives of physiologically active substance k-252.
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
NO174202C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktivt azainden-derivater
IE873125L (en) Benzimidazole derivatives
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
IT1228288B (it) Composti ad attivita' antiserotoninica
DE69004119D1 (de) Entzündungshemmende Arylderivate.
ATE92036T1 (de) Kardiovaskulaer aktive verbindungen.
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
DE3584608D1 (de) Amidabkoemmlinge.
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
DK644487A (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
ATE92037T1 (de) Kardiovaskulaer aktive verbindungen.
FR2567755B1 (fr) Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it